1. 2766 Safety of bevacizumab-containing neoadjuvant therapy followed by interval debulking surgery in advanced ovarian cancer: Data from the ANTHALYA trial. (September 2015) Authors: Selle, F.; Gouy, S.; Lambaudie, E.; Guyon, F.; Fourchotte, V.; Pomel, C.; Colombo, P.E.; Kalbacher, E.; Martin-Francoise, S.; Fauvet, R.; Follana, P.; Lesoin, A.; Lecuru, F.; Menguy, V.; Ghazi, Y.; Chereau, E.; Zohar, S.; Cottu, P.; Joly, F.; Rouzier, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2740 Independent review committee assessment of Fagotti carcinomatosis score from 8 laparoscopic images: Ancillary analysis of ANTHALYA, a randomized, open-label, phase II study assessing the efficacy and safety of bevacizumab addition to neoadjuvant therapy for women with ovarian, tubal or peritoneal adenocarcinoma, initially unresectable. (September 2015) Authors: Chéreau, E.; Gouy, S.; Lambaudie, E.; Ballester, M.; Fourchotte, V.; Guyon, F.; Pomel, C.; Colombo, P.E.; Delroeux, D.; Martin-Francoise, S.; Bihan, C.; Leblanc, E.; Lecuru, F.; Fouche, Y.; Ghazi, Y.; Pau, D.; Selle, F.; Cottu, P.; Joly, F.; Rouzier, R. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S543 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 2755 First real life data on Olaparib in BRCA1/2 mutated Platinum-Sensitive Relapsed (PSR) Epithelial Ovarian Cancer (EOC) in France: Analysis of 52 patients (pts) enrolled in the French Temporary Authorization for Use (ATU). (September 2015) Authors: De La Motte Rouge, T.; Pautier, P.; Alexandre, J.; Ray-Coquard, I.; Cottu, P.; Rodrigues, M.; Follana, P.; Floquet, A.; Lortholary, A.; Heudel, P.E.; Combe, P.; Joly, F.; Suau, D.; Maribas, D.; Licour, M.; Porte, I. De La; Varoqueaux, N.; Pujade-Lauraine, E. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 2772 Circulating tumor cells kinetics in ovarian carcinoma: correlation with baseline characteristics and CA-125 levels in the randomized ANTHALYA trial evaluating bevacizumab in the neoadjuvant setting. (September 2015) Authors: Cottu, P.; Rouge, T. De La Motte; Pautier, P.; Provansal, M.; Floquet, A.; Selle, F.; Mouret-Reynier, M.A.; Fabbro, M.; Kalbacher, E.; Piprot, C.; Follana, P.; Lesoin, A.; Medioni, J.; Menguy, V.; Ghazi, Y.; Bidard, F.C.; Dubot, C.; Joly, F. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S555 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO-0967: Toxicity of concurrent Palbociclib and Radiation therapy in metastatic breast cancer patients. (November 2020) Authors: Beddok, A.; Arsene-Henry, A.; Porte, B.; Cao, K.; Bazire, L.; Scher, N.; Otz, J.; Minsat, M.; Bidard, F.; Fourquet, A.; Cottu, P.; Poortmans, P.; Kirova, Y. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Use of oral complementary-alternative medicine (OCAM) and fatigue among early breast cancer (BC) patients (pts). (October 2020) Authors: Djehal, N.; Havas, J.; Gbenou, A.; Martin, E.; Charles, C.; Dauchy, S.; Pistilli, B.; Cadeau, C.; Arveux, P.; Everhard, S.; Lemonnier, J.; Coutant, C.; Cottu, P.; Lesur, A.; Menvielle, G.; Dumas, A.; Andre, F.; Michiels, S.; Vaz-Luis, I.; Di Meglio, A. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The COVID-19 outbreak may be associated to a reduced level of care for breast cancer. A comparative study with the pre-COVID era in an Italian Breast Unit. (October 2020) Authors: Fancellu, A.; Sanna, V.; Piredda, C.; Ariu, L.; Piana, G.Q.; Deiana, G.; Cottu, P.; Giuliani, G.; Porcu, A. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Usefulness of locoregional nerve blocks in breast surgery. A comparative study. (October 2020) Authors: Fancellu, A.; Perra, T.; Terragni, P.; Arghittu, P.; Cottu, P.; Ninniri, M.C.; Deiana, G.; Piredda, C.; Sanna, V.; Porcu, A. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. MO-0800 CANTO-RT: Skin toxicities evaluation of prospective cohort of irradiated patients for breast cancer. (May 2022) Authors: allali, S.; Carton, M.; Sarrade, T.; Everhard, S.; Querel, O.; Rivera, S.; Peignaux, K.; Guilbert, P.; Chara-Brunaud, C.; Blanchecotte, J.; Labib, A.; Pasquier, D.; Racadot, S.; Bourgier, C.; Julien, G.; Cottu, P.; Vaz-Luis, I.; Kirova, Y. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and tolerance of everolimus in 123 consecutive advanced ER positive, HER2 negative breast cancer patients. A two center retrospective study. Issue 6 (December 2015) Authors: Chocteau-Bouju, D.; Chakiba, C.; Mignot, L.; Madranges, N.; Pierga, J.-Y.; Beuzeboc, P.; Quenel-Tueux, N.; Dieras, V.; Bonnefoi, H.; Debled, M.; Cottu, P. Journal: Breast Issue: Volume 24:Issue 6(2015) Page Start: 718 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗